Skip to main content
Signal8

OConnell Daniel Joseph

SEC insider (Form 3/4/5 filer). CIK 0001865136. Chief Executive Officer at Acumen Pharmaceuticals, Inc. (ABOS). 12 reported Form 4/5 transactions since Sep 2024; latest on Jan 22, 2026. Located in NEWTON, MA.

Companies OConnell Daniel Joseph has filed insider reports for

  • Acumen Pharmaceuticals, Inc. (ABOS): Director, Officer, Chief Executive Officer
OConnell Daniel Joseph profile photo

OConnell Daniel Joseph

CIK: 0001865136

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Acumen Pharmaceuticals, Inc. logo
ABOS

Acumen Pharmaceuticals, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 22, 2026
    Sale
    Direct
    2.7K shares at avg. $1.88$5K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 21, 2026
    Sale
    Direct
    9.3K shares at avg. $1.81$17K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 20, 2026
    Award
    Direct
    299.8K shares-
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 12, 2026
    Sale
    Direct
    5.4K shares at avg. $1.73$9K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 9, 2026
    Sale
    Direct
    12.9K shares at avg. $1.76$23K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 8, 2026
    Sale
    Direct
    8.1K shares at avg. $1.82$15K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 7, 2026
    Sale
    Direct
    37.8K shares at avg. $1.99$75K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 6, 2026
    Sale
    Direct
    5.1K shares at avg. $1.97$10K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 5, 2026
    Sale
    Direct
    4.6K shares at avg. $1.97$9K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 21, 2025
    Sale
    Direct
    12.6K shares at avg. $1.59$20K

1-10 of 12